Please login to the form below

Not currently logged in
Email:
Password:

BrightGene

This page shows the latest BrightGene news and features for those working in and with pharma, biotech and healthcare.

UPDATED: Gilead drops remdesivir’s orphan drug designation

UPDATED: Gilead drops remdesivir’s orphan drug designation

Chinese pharma company BrightGene also alleged that it had successfully copied remdesivir and had plans to manufacture a generic version of the drug. ... The SSE said that BrightGene had not gained approval from China’s drug regulator to manufacture

Latest news

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

Top 10 ways to leverage the Impetus InSite Platform® to (virtually) launch your brand
The Impetus InSite Platform® can be used to facilitate virtual and hybrid engagement at all stages of the product lifecycle. Here, we share 10 of the most popular ways to...
Employee wellbeing in creative agencies: three tips to get you started
Paul Hutchings, founder of fox&cat, and new friend, Welfy, a workplace wellbeing training firm, discuss the importance of collaboration...
Managing unhelpful pressure in your creative agency: the human approach
Paul Hutchings, founder of fox&cat, answers the questions: what does it mean to be human in 2021? Are we putting ourselves under too much pressure?...